ab9549 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab9549 は 8 報の論文で使用されています。

  • Ketley A  et al. High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines. Hum Mol Genet N/A:N/A (2013). WB ; Human . PubMed: 24179176
  • Tang ZZ  et al. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel. Hum Mol Genet 21:1312-24 (2012). WB ; Mouse . PubMed: 22140091
  • Mykowska A  et al. CAG repeats mimic CUG repeats in the misregulation of alternative splicing. Nucleic Acids Res 39:8938-51 (2011). WB ; Human . PubMed: 21795378
  • Clower CV  et al. The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc Natl Acad Sci U S A 107:1894-9 (2010). WB ; Human . PubMed: 20133837
  • Kanadia RN  et al. Temporal requirement of the alternative-splicing factor Sfrs1 for the survival of retinal neurons. Development 135:3923-33 (2008). WB ; Mouse . PubMed: 18987029
  • Kress C  et al. Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice. Mol Cell Biol 27:1146-57 (2007). PubMed: 17130239
  • Wang GS  et al. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J Clin Invest 117:2802-11 (2007). IHC (PFA fixed) . PubMed: 17823658
  • Timchenko LT  et al. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res 24:4407-14 (1996). PubMed: 8948631

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"